IL‐1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence‐associated secretory phenotype |
| |
Authors: | Kimberley A. Wiggins Aled J. Parry Liam D. Cassidy Melanie Humphry Steve J. Webster Jane C. Goodall Masashi Narita Murray C. H. Clarke |
| |
Affiliation: | 1. Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK;2. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK;3. Division of Rheumatology, Department of Medicine, University of Cambridge, Cambridge, UK;4. https://orcid.org/0000-0002-8215-8885;5. Murray C. H. Clarke, Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK. |
| |
Abstract: | Interleukin‐1 alpha (IL‐1α) is a powerful cytokine that modulates immunity, and requires canonical cleavage by calpain for full activity. Mature IL‐1α is produced after inflammasome activation and during cell senescence, but the protease cleaving IL‐1α in these contexts is unknown. We show IL‐1α is activated by caspase‐5 or caspase‐11 cleavage at a conserved site. Caspase‐5 drives cleaved IL‐1α release after human macrophage inflammasome activation, while IL‐1α secretion from murine macrophages only requires caspase‐11, with IL‐1β release needing caspase‐11 and caspase‐1. Importantly, senescent human cells require caspase‐5 for the IL‐1α‐dependent senescence‐associated secretory phenotype (SASP) in vitro, while senescent mouse hepatocytes need caspase‐11 for the SASP‐driven immune surveillance of senescent cells in vivo. Together, we identify IL‐1α as a novel substrate of noncanonical inflammatory caspases and finally provide a mechanism for how IL‐1α is activated during senescence. Thus, targeting caspase‐5 may reduce inflammation and limit the deleterious effects of accumulated senescent cells during disease and Aging. |
| |
Keywords: | caspase IL‐1 IL‐1 alpha inflammasome inflammation senescence senescence‐associated secretory phenotype |
|
|